# Single-cell and spatial transcriptomics reveal transplant-associated T cells and myeloid cells in human liver transplantation

**Authors:** Tianyang Zhou, Kun Guo, Chengyong Dong, Yuhui Wang, Jiajun Gao, Zhenyu Xu, Zhaoyun Shi, Zhiqi Jiao, Cong Xia, Ke Hu, Zhenming Gao

PMC · DOI: 10.3389/fimmu.2026.1745647 · Frontiers in Immunology · 2026-02-04

## TL;DR

This study uses advanced techniques to map immune cells in liver transplants, revealing how specific T cell subsets contribute to rejection.

## Contribution

The study identifies novel transplantation-associated T cell subsets and their spatial dynamics in human liver grafts.

## Key findings

- Transplant-associated T cell subsets like CD4+ Teff_like and CD8+ tTeff_like are linked to immune activity in rejection.
- Monocyte_PPARG cells may be recruited by CD4+ Teff_like cells and influence CD8+ T cell differentiation.
- Spatial transcriptomics shows that these immune subsets dominate in rejecting liver grafts.

## Abstract

Liver transplantation is the only effective way for end-stage liver disease. Rejection remains the leading cause of graft failure. The dynamic changes of intrahepatic immune cells involved in rejection are not completely understood.

We integrated single-cell RNA sequencing and spatial transcriptomics (ST) to analyze graft tissues from multiple stages of human liver transplantation. ST enabled high-resolution mapping of immune cell states and spatial distribution within liver grafts.

We identified several transplantation-associated T cell (taT) subsets, including CD4+ effector-like T cells (Teff_like), CD8+ precursor exhausted T cells (Tpex), and CD8+ transitional effector-like T cells (tTeff_like). The CD4+ Teff_like subset highly expressed chemokines such as CCL3. The CD8+ tTeff_like subset represented an intermediate state transitioning from the CD8+ Tpex subset toward terminal exhaustion and was enriched in the immune activity pathway. Monocyte_PPARG, enriched in the rejection group, may be recruited by CD4+ Teff_like via the MIF-(CD74+CD44) pathway and subsequently promote CD8+ Tpex to tTeff_like differentiation through the ICAM1-LFA1 pathway. ST suggested that these immune subsets dominated the rejecting liver grafts.

These findings highlight the potential roles and spatial distribution of taT subsets in rejecting liver grafts, providing insights into local immune regulation and the development of targeted therapeutic strategies.

## Linked entities

- **Genes:** CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348], PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468], CD74 (CD74 molecule) [NCBI Gene 972], CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960], ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383], ITGAL (integrin subunit alpha L) [NCBI Gene 3683]
- **Diseases:** end-stage liver disease (MONDO:0100193)

## Full-text entities

- **Genes:** TOX (thymocyte selection associated high mobility group box) [NCBI Gene 9760] {aka TOX1}, MIF (macrophage migration inhibitory factor) [NCBI Gene 4282] {aka GIF, GLIF, MMIF}, IFNA1 (interferon alpha 1) [NCBI Gene 3439] {aka IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@}, CCL4 (C-C motif chemokine ligand 4) [NCBI Gene 6351] {aka ACT2, AT744.1, G-26, HC21, LAG-1, LAG1}, PRDM1 (PR/SET domain 1) [NCBI Gene 639] {aka BLIMP-1, BLIMP1, PRDI-BF1}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, ITGA4 (integrin subunit alpha 4) [NCBI Gene 3676] {aka CD49D, IA4}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, FHIT (fragile histidine triad diadenosine triphosphatase) [NCBI Gene 2272] {aka AP3Aase, FRA3B}, IL7R (interleukin 7 receptor) [NCBI Gene 3575] {aka CD127, CDW127, IL-7R-alpha, IL-7Ralpha, IL7RA, IL7Ralpha}, RFX3 (regulatory factor X3) [NCBI Gene 5991], SELL (selectin L) [NCBI Gene 6402] {aka CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, ITGAL (integrin subunit alpha L) [NCBI Gene 3683] {aka CD11A, EV6, HNA-5, LFA-1, LFA1A}, CD27 (CD27 molecule) [NCBI Gene 939] {aka S152, S152. LPFS2, T14, TNFRSF7, Tp55}, RORA (RAR related orphan receptor A) [NCBI Gene 6095] {aka IDDECA, NR1F1, ROR1, ROR2, ROR3, RORa1}, PPARG (peroxisome proliferator activated receptor gamma) [NCBI Gene 5468] {aka CIMT1, FPLD3, GLM1, NR1C3, PPARG1, PPARG2}, CENPF (centromere protein F) [NCBI Gene 1063] {aka CENF, CILD31, PRO1779, STROMS, hcp-1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, ITGB2 (integrin subunit beta 2) [NCBI Gene 3689] {aka CD18, LAD, LCAMB, LFA-1, MAC-1, MF17}, ITGB1 (integrin subunit beta 1) [NCBI Gene 3688] {aka CD29, FNRB, GPIIA, MDF2, MSK12, VLA-BETA}, CTNNB1 (catenin beta 1) [NCBI Gene 1499] {aka CTNNB, EVR7, MRD19, NEDSDV, armadillo}, CD69 (CD69 molecule) [NCBI Gene 969] {aka AIM, BL-AC/P26, CLEC2C, EA1, GP32/28, MLR-3}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, GZMK (granzyme K) [NCBI Gene 3003] {aka GrK, TRYP2}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}, TIGIT (T cell immunoreceptor with Ig and ITIM domains) [NCBI Gene 201633] {aka VSIG9, VSTM3, WUCAM}, VCAM1 (vascular cell adhesion molecule 1) [NCBI Gene 7412] {aka CD106, INCAM-100}, GZMA (granzyme A) [NCBI Gene 3001] {aka CTLA3, HFSP}, LCK (LCK proto-oncogene, Src family tyrosine kinase) [NCBI Gene 3932] {aka IMD22, LSK, YT16, p56lck, pp58lck}, MTOR (mechanistic target of rapamycin kinase) [NCBI Gene 2475] {aka FRAP, FRAP1, FRAP2, RAFT1, RAPT1, SKS}, CTLA4 (cytotoxic T-lymphocyte associated protein 4) [NCBI Gene 1493] {aka ALPS5, CD, CD152, CELIAC3, CTLA-4, GRD4}, PRF1 (perforin 1) [NCBI Gene 5551] {aka HPLH2, P1, PFP}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NKG7 (natural killer cell granule protein 7) [NCBI Gene 4818] {aka GIG1, GMP-17, p15-TIA-1}, CCL5 (C-C motif chemokine ligand 5) [NCBI Gene 6352] {aka D17S136E, RANTES, SCYA5, SIS-delta, SISd, TCP228}, TRBV20OR9-2 (T cell receptor beta variable 20/OR9-2 (non-functional)) [NCBI Gene 6962] {aka CDR3, TCRBV20S2, TCRBV2O, TCRBV2S2O}, IRF4 (interferon regulatory factor 4) [NCBI Gene 3662] {aka IMD131, LSIRF, MUM1, NF-EM5, SHEP8}, KLRB1 (killer cell lectin like receptor B1) [NCBI Gene 3820] {aka CD161, CLEC5B, NKR, NKR-P1, NKR-P1A, NKRP1A}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, CCL3 (C-C motif chemokine ligand 3) [NCBI Gene 6348] {aka G0S19-1, LD78, LD78ALPHA, MIP-1-alpha, MIP1A, SCI}, ITGA1 (integrin subunit alpha 1) [NCBI Gene 3672] {aka CD49a, VLA1}, RUNX2 (RUNX family transcription factor 2) [NCBI Gene 860] {aka AML3, CBF-alpha-1, CBFA1, CCD, CCD1, CLCD}, CAP1 (cyclase associated actin cytoskeleton regulatory protein 1) [NCBI Gene 10487] {aka CAP, CAP1-PEN}, ICAM1 (intercellular adhesion molecule 1) [NCBI Gene 3383] {aka BB2, CD54, P3.58}, CD8B (CD8 subunit beta) [NCBI Gene 926] {aka CD8B1, CD8beta, LEU2, LY3, LYT3, Ly-3}, SERPINB2 (serpin family B member 2) [NCBI Gene 5055] {aka HsT1201, PAI, PAI-2, PAI2, PLANH2}, CD68 (CD68 molecule) [NCBI Gene 968] {aka GP110, LAMP4, SCARD1}, CD1E (CD1e molecule) [NCBI Gene 913] {aka R2}, NFKB1 (nuclear factor kappa B subunit 1) [NCBI Gene 4790] {aka CVID12, EBP-1, KBF1, NF-kB, NF-kB1, NF-kappa-B1}, ZBTB16 (zinc finger and BTB domain containing 16) [NCBI Gene 7704] {aka PLZF, ZNF145}, GZMH (granzyme H) [NCBI Gene 2999] {aka CCP-X, CGL-2, CSP-C, CTLA1, CTSGL2}, CDKN1C (cyclin dependent kinase inhibitor 1C) [NCBI Gene 1028] {aka BWCR, BWS, KIP2, WBS, p57, p57Kip2}, LEF1 (lymphoid enhancer binding factor 1) [NCBI Gene 51176] {aka ECTD1, ECTD17, LEF-1, TCF10, TCF1ALPHA, TCF7L3}, PDCD1 (programmed cell death 1) [NCBI Gene 5133] {aka ADMIO4, AIMTBS, CD279, PD-1, PD1, SLEB2}, CCL3L3 (C-C motif chemokine ligand 3 like 3) [NCBI Gene 414062] {aka 464.2, D17S1718, G0S19-2, LD78, LD78BETA, SCYA3L}, EOMES (eomesodermin) [NCBI Gene 8320] {aka TBR2}, TCF7 (transcription factor 7) [NCBI Gene 6932] {aka TCF-1}, CD44 (CD44 molecule (IN blood group)) [NCBI Gene 960] {aka CDW44, CSPG8, ECM-III, ECMR-III, H-CAM, HCELL}
- **Diseases:** ST (MESH:D008569), liver failure (MESH:D017093), cytotoxic (MESH:D064420), end-stage liver disease (MESH:D058625), brain death (MESH:D001926), HD (MESH:D006816), inflammation (MESH:D007249)
- **Chemicals:** DAPI (MESH:C007293), Formalin (MESH:D005557), steroid (MESH:D013256), tacrolimus (MESH:D016559), H&amp;E (MESH:D006371), GSVA (-), paraffin (MESH:D010232)
- **Species:** Homo sapiens (human, species) [taxon 9606], Rattus norvegicus (brown rat, species) [taxon 10116]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12913157/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12913157/full.md

## References

53 references — full list in the complete paper: https://tomesphere.com/paper/PMC12913157/full.md

---
Source: https://tomesphere.com/paper/PMC12913157